Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Insight Molecular Diagnostics Inc. (IMDX) vs MedX Health Corp. (MDXHF)

Insight Molecular Diagnostics Inc. and MedX Health Corp. are both Diagnostics & Research companies. Insight Molecular Diagnostics Inc. is the larger, with a market value of $129.3M against $103.2M — 1.3× the size. MedX Health Corp. grew revenue faster over the last twelve months: 9.96% against −60.8%. MedX Health Corp. has the higher net margin (−1,095.0% vs −2,955.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Insight Molecular Diagnostics Inc. leads on 9 and MedX Health Corp. on 7.

Valuation

Metric IMDX MDXHF Diagnostics & Research median
P/E n/m n/m 33.95
P/S 86.26 25.16 4.87
P/B n/m n/m 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 75.74 30.65 5.66
Earnings yield (38.01%) (46.00%) (1.75%)
Free cash flow yield (21.52%) (55.11%) (0.13%)

Profitability

Metric IMDX MDXHF Diagnostics & Research median
Gross margin 48.32% (6.88%) 50.89%
Operating margin (3,011.86%) (742.33%) (8.57%)
Net margin (2,955.63%) (1,094.99%) (6.37%)
Free cash flow margin (1,856.23%) (999.18%) 0.00%
Return on equity 488.68% 63.45% (2.92%)
Return on assets (123.46%) (867.29%) (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMDX MDXHF Diagnostics & Research median
Revenue growth (TTM) (60.77%) 9.96% 7.69%
EPS growth (last fiscal year) 64.59% (52.00%) —
Revenue growth, 5-year CAGR 27.24% (55.05%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMDX MDXHF Diagnostics & Research median
Debt to equity (0.04) (0.32) 0.11
Current ratio 2.00 0.04 2.02
Net debt to EBITDA (0.67) (0.40) 0.78

Dividend

Metric IMDX MDXHF Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric IMDX MDXHF Diagnostics & Research median
Market cap 129.26m 103.16m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack